CSL (OTCMKTS:CSLLY) Shares Gap Down – Here’s What Happened

Shares of CSL Limited Sponsored ADR (OTCMKTS:CSLLY) gapped down before the market opened on Thursday . The stock had previously closed at $60.97, but opened at $57.22. CSL shares last traded at $59.7090, with a volume of 14,831 shares.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Canaccord Genuity Group raised shares of CSL from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 28th. Zacks Research cut CSL from a “hold” rating to a “strong sell” rating in a research note on Tuesday, November 18th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

CSL Trading Down 1.7%

The business’s 50 day simple moving average is $62.74 and its 200-day simple moving average is $72.19. The company has a quick ratio of 1.12, a current ratio of 2.46 and a debt-to-equity ratio of 0.50.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.